Document Detail


Subintimal angioplasty with a true reentry device for treatment of chronic total occlusion of the arteries of the lower extremity.
MedLine Citation:
PMID:  20824749     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To report the efficacy and safety of the Outback(®) LTD(®) Re-Entry Catheter in reentering the distal true lumen during percutaneous intentional extraluminal revascularization (PIER).
BACKGROUND: Reentry catheters are used to treat chronic, total arterial occlusions of the lower extremities when standard methods of recanalization have failed. Success and complication rates of these catheters in the real world are uncertain and variable.
METHODS: A retrospective review of our peripheral catheterization database from January 2004 to September 2009 was undertaken to identify consecutive cases of peripheral chronic total occlusions (CTOs) requiring the use of the Outback reentry catheter. Patient demographics, indication for the procedure, location and extent of occlusion, procedural success, and complications were studied.
RESULTS: A total of 51 patients were identified. Of the 51, 28 (54.9%) patients presented with nonhealing ulcer and 22 (43.1%) had lifestyle-limiting claudication. One patient presented with acute limb ischemia. There were 6 (11.8%) patients with common iliac artery occlusion, 2 (3.9%) with external iliac artery occlusion, 1 (1.9%) with common femoral artery occlusion, 35 (68.6%) with superficial femoral artery occlusion, 6 (11.8%) with popliteal artery occlusion, and 1 (1.9%) with tibioperoneal artery occlusion. Median lesion length was 230 mm. Procedural success was achieved in 49 patients (96.1%). There was 1 (1.9%) periprocedural complication.
CONCLUSION: Use of Outback(®) LTD(®) Re-Entry Catheter is a safe and valuable option for PIER/subintimal angioplasty and recanalization in patients with symptomatic lower-extremity CTOs. However, long-term patency remains unknown. © 2012 Wiley Periodicals, Inc.
Authors:
Mohammad Shakil Aslam; Suhail Allaqaband; Babak Haddadian; Naoyo Mori; Tanvir Bajwa; Mark Mewissen
Related Documents :
17049179 - Influence of duration of focal cerebral ischemia and neuronal nitric oxide synthase on ...
7931589 - Cerebral damage caused by interrupted, repeated arterial occlusion versus uninterrupted...
9855199 - Approaches to study of ischemia in bone.
6333149 - Experimental evaluation of intraarterial occlusion-infusion chemotherapy.
10903189 - Macroangiopathy of the upper extremities in progressive systemic sclerosis.
750079 - Transmural triglycerides in acute myocardial ischaemia.
3899649 - Diagnosis of tricuspid regurgitation. sensitivity of doppler ultrasound compared with c...
20591319 - Double internal carotid origin of the ophthalmic artery with ruptured aneurysm of the p...
23304599 - Left pulmonary artery thrombosis in a neonate with left lung hypoplasia.
Publication Detail:
Type:  Journal Article     Date:  2013-03-28
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  82     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-10-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  701-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Affiliation:
Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, Milwaukee, Wisconsin.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sheathless transradial intervention using standard guide catheters.
Next Document:  Frequency and risk of noncardiac surgery after drug-eluting stent implantation.